The Rate of Bloodstream Infection Is High in Infants with Short Bowel Syndrome: Relationship with Small Bowel Bacterial Overgrowth, Enteral Feeding, and Inflammatory and Immune Responses

Journal of Pediatrics

Volumn 156, Issue 6, 2010, Pages

  Cole, Conrad R ^a   Frem, Juliana C ^c   Schmotzer, Brian ^b   Gewirtz, Andrew T ^a   Meddings, Jonathan B ^d   Gold, Benjamin D ^a   Ziegler, Thomas R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; FLAGELLIN; IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL OVERGROWTH; BLOODSTREAM INFECTION; CHILD; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERIC FEEDING; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNE RESPONSE; INFANT; INFECTION RISK; INFLAMMATION; INTESTINE MUCOSA PERMEABILITY; KLEBSIELLA PNEUMONIAE; LEUCONOSTOC; MALE; NECROTIZING ENTEROCOLITIS; PARENTERAL NUTRITION; PRESCHOOL CHILD; PRIORITY JOURNAL; SHORT BOWEL SYNDROME;

EID: 77952290360     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.12.008     Document Type: Article

References (30)

1. Schwartz M.Z., and Maeda K. Short bowel syndrome in infants and children. Pediatr Clin North Am 32 (1985) 1265-1279
2. Cole C.R., Hansen N.I., Higgins R.D., Ziegler T.R., Stoll B.J., and for the Eunice Kennedy Shriver Neonatal Research Network. Very low birth weight preterm infants with surgical short bowel syndrome: Incidence, morbidity and mortality, and growth outcomes at 18 to 22 months. Pediatrics 122 (2008) e573-e582
3. Beau P., Barrioz T., and Ingrand P. Total parenteral nutrition-related cholestatic hepatopathy, is it an infectious disease?. Gastroenterol Clin Biol 18 (1994) 63-67
4. Spencer A.U., Kovacevich D., McKinney-Barnett M., Hair D., Canham J., Maksym C., et al. Pediatric short-bowel syndrome: the cost of comprehensive care. Am J Clin Nutr 88 (2008) 1552-1559
5. Terra R.M., Plopper C., Waitzberg D.L., Cukier C., Santoro S., Martins J.R., et al. Remaining small bowel length: association with catheter sepsis in patients receiving home total parenteral nutrition: evidence of bacterial translocation. World J Surg 24 (2000) 1537-1541
6. Sondheimer J.M., Asturias E., and Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 27 (1998) 131-137
7. Kaufman S.S., Loseke C.A., Lupo J.V., Young R.J., Murray N.D., Pinch L.W., et al. Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome. J Pediatr 131 (1997) 356-361
8. Shimizu K., Ogura H., Goto M., Asahara T., Nomoto K., Morotomi M., et al. Altered gut flora and environment in patients with severe SIRS. J Trauma 60 (2006) 126-133
9. Ziegler T.R., Evans M.E., Fernandez-Estivariz C., and Jones D.P. Trophic and cytoprotective nutrition for intestinal adaptation, mucosal repair, and barrier function. Annu Rev Nutr 23 (2003) 229-261
10. Gewirtz A.T. Flag in the crossroads: flagellin modulates innate and adaptive immunity. Curr Opin Gastroenterol 22 (2006) 8-12
11. Ziegler T.R., Luo M., Estivariz C.F., Moore III D.A., Sitaraman S.V., Hao L., et al. Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome. Am J Physiol Regul Integr Comp Physiol 294 (2008) R402-R410
12. Gewirtz A.T., Navas T.A., Lyons S., Godowski P.J., and Madara J.L. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 167 (2001) 1882-1885
13. Bunn S.K., Bisset W.M., Main M.J., Gray E.S., Olson S., and Golden B.E. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 33 (2001) 14-22
14. Fagerberg U.L., Loof L., Myrdal U., Hansson L.O., and Finkel Y. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr 40 (2005) 450-455
15. Diamond I.R., de Silva N., Pencharz P.B., Kim J.H., and Wales P.W. Neonatal short bowel syndrome outcomes after the establishment of the first Canadian multidisciplinary intestinal rehabilitation program: preliminary experience. Journal of Pediatric Surgery 42 (2007) 806-811
16. Touloukian R.J., and Smith G.J. Normal intestinal length in preterm infants. J. Pediatr Surg 18 (1983) 720-723
17. nd ed. (2005), Oxford University Press, New York 41-64
18. de Boissieu D., Chaussain M., Badoual J., Raymond J., and Dupont C. Small-bowel bacterial overgrowth in children with chronic diarrhea, abdominal pain, or both. J Pediatr 128 (1996) 203-207
19. Sigalet D.L., Martin G., Meddings J., Hartman B., and Holst J.J. GLP-2 levels in infants with intestinal dysfunction. Pediatr Res 56 (2004) 371-376
20. Ton H., Brandsnes, Dale S., Holtlund J., Skuibina E., Schjonsby H., et al. Improved assay for fecal calprotectin. Clin Chim Acta 292 (2000) 41-54
21. Perman J.A., Modler S., Barr R.G., and Rosenthal P. Fasting breath hydrogen concentration: normal values and clinical applications. Gastroenterology 87 (1984) 1358-1363
22. Sigalet D.L., Martin G.R., and Meddings J.B. 3-0 methylglucose uptake as a marker of nutrient absorption and bowel length in pediatric patients. JPEN J Parenter Enteral Nutr 28 (2004) 158-162
23. Marsilio R., D'Antiga L., Zancan L., Dussini N., and Zacchello F. Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics. Clinical Chemistry 44 (1998) 1685-1691
24. Cole C.R., and Ziegler T.R. Small bowel bacterial overgrowth: a negative factor in gut adaptation in pediatric SBS. Curr Gastroenterol Rep 9 (2007) 456-462
25. Vanderhoof J.A. New and emerging therapies for short bowel syndrome in children. J Pediatr Gastroenterol Nutr 39 Suppl 3 (2004) S769-S771
26. Cole C.R., Rising R., and Lifshitz F. Consequences of incomplete carbohydrate absorption from fruit juice consumption in infants. Arch Pediatr Adolesc Med 153 (1999) 1098-1102
27. Corazza G.R., Menozzi M.G., Strocchi A., Rasciti L., Vaira D., Lecchini R., et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 98 (1990) 302-309
28. O'Dwyer S.T., Michie H.M., Ziegler T.R., Revhaug A., Smith R.J., and Wilmore D.W. A single dose of endotoxin alters intestinal permeability in healthy humans. Arch Surg 123 (1988) 1459-1464
29. Tian J, Hao L, Chandra P, Jones DP, Williams IR, Gewirtz AT, Ziegler TR. 2009 Dietary glutamine and oral antibiotics each improve indices of gut barrier function in rat short bowel syndrome. Am J Physiol 296:G348-G355.
30. D'L, Dhawan A., Davenport M., Mieli-Vergani G., and Bjarnason I. Intestinal absorption and permeability in paediatric short-bowel syndrome: a pilot study. J Pediatr Gastroenterol Nutr 29 (1999) 588-593